Joel Z Melnick

This inventor holds 16 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Vitamin D Formulations. Top assignees: Opko Ireland Global Holdings, Limited, Eirgen Pharma Ltd., Opko Renal, LLC. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel Z Melnick. Retrieved from https://idiyas.com/inventor/joel-z-melnick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 99(Granted Patents)

Location History:

Miami, FL (US) (2019)
Wilmette, IL (US) (2015 - 2023)
Evanston, IL (US) (2019 - 2023)

Company Filing History:

8 out of 24

Opko Ireland Global Holdings, Limited

Opko IP Holdings Ii, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Vitamin D

Formulation

Stabilized Release

Adjunctive Therapy

Parathyroid Levels

Chronic Kidney Disease

Vitamin D Deficiency

25-Hydroxyvitamin D

Treatment Methods

Insufficiency

Compositions

Administration

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478631 - Stabilized modified release vitamin D formulation and method of administering same (2025-11-25),

2. 12208106 - Methods of vitamin D treatment (2025-01-28),

3. 11738033 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2023-08-29),

4. 11672809 - Methods and compositions for reducing parathyroid levels (2023-06-13),

5. 11253528 - Stabilized modified release Vitamin D formulation and method of administering same (2022-02-22),

6. 11173168 - Methods of treating vitamin D insufficiency in chronic kidney disease (2021-11-16),

7. 11007205 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2021-05-18),

8. 10493084 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2019-12-03),

9. 10357502 - Stabilized modified release vitamin D formulation and method of administering same (2019-07-23),

10. 10350224 - Stabilized modified release vitamin D formulation and method of administering same (2019-07-16),

11. 10302660 - Methods useful for vitamin D deficiency and related disorders (2019-05-28),

12. 10300078 - Stabilized modified release vitamin D formulation and method of administering same (2019-05-28),

13. 10220047 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2019-03-05),

14. 9861644 - Stabilized modified release vitamin D formulation and method of administering same (2018-01-09),

15. 9500661 - Methods useful for vitamin D deficiency and related disorders (2016-11-22),

Title: The Innovative Contributions of Joel Z Melnick

Introduction

Joel Z Melnick is a prominent inventor based in Wilmette, Illinois. He has made significant contributions to the field of medicine, particularly in the treatment of vitamin D insufficiency and related conditions. With a total of 15 patents to his name, Melnick's work has the potential to impact many patients suffering from chronic kidney disease and other related health issues.

Latest Patents

Melnick's latest patents focus on innovative methods for vitamin D treatment. One of his notable patents discloses methods for treating vitamin D insufficiency and secondary hyperparathyroidism in patients with chronic kidney disease. This involves administering repeat doses of 25-hydroxyvitamin D to safely raise the patient's serum levels. Another patent outlines methods, compositions, and kits for adjunctive therapy using 25-hydroxyvitamin D, which may be administered alongside agents that increase the risk of hypocalcemia. This therapy aims to treat and prevent iatrogenic hypocalcemia and secondary hyperparathyroidism, while also delaying cancer progression.

Career Highlights

Throughout his career, Melnick has worked with notable companies such as Opko Ireland Global Holdings, Limited and Eirgen Pharma Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Melnick has collaborated with esteemed colleagues, including P Martin Petkovich and Jay A White. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the medical field.

Conclusion

Joel Z Melnick's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving patient care. His work in vitamin D treatment has the potential to make a significant difference in the lives of many individuals.

Profile summary based on public USPTO records.